These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12295 related articles for article (PubMed ID: 10624865)

  • 1. Reduction of cisplatin-induced nephrotoxicity by cystone, a polyherbal ayurvedic preparation, in C57BL/6J mice bearing B16F1 melanoma without reducing its antitumor activity.
    Rao M; Praveen Rao PN; Kamath R; Rao MN
    J Ethnopharmacol; 1999 Dec; 68(1-3):77-81. PubMed ID: 10624865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of cystone, a polyherbal ayurvedic preparation, on cisplatin-induced renal toxicity in rats.
    Rao M; Rao MN
    J Ethnopharmacol; 1998 Aug; 62(1):1-6. PubMed ID: 9720605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the protective effect of Cystone against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity.
    El-Ghiaty MA; Ibrahim OM; Abdou SM; Hussein FZ
    Int Urol Nephrol; 2014 Jul; 46(7):1367-73. PubMed ID: 24448757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
    Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
    J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity.
    Ma SF; Nishikawa M; Hyoudou K; Takahashi R; Ikemura M; Kobayashi Y; Yamashita F; Hashida M
    Kidney Int; 2007 Dec; 72(12):1474-82. PubMed ID: 17898699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C protects against cisplatin-induced nephrotoxicity and damage without reducing its effectiveness in C57BL/6 mice xenografted with Lewis lung carcinoma.
    Chen MF; Yang CM; Su CM; Hu ML
    Nutr Cancer; 2014; 66(7):1085-91. PubMed ID: 25157954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
    Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
    Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent nephrotoxicity associated with daily administration of cisplatin in mice.
    To H; Kikuchi A; Tsuruoka S; Sugimoto K; Fujimura A; Higuchi S; Kayama F; Hara K; Matsuno K; Kobayashi E
    J Pharm Pharmacol; 2000 Dec; 52(12):1499-504. PubMed ID: 11197078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of betamipron on cisplatin nephrotoxicity and its pharmacokinetics in rats.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Biol Pharm Bull; 1997 Apr; 20(4):386-91. PubMed ID: 9145215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pericarp extract of Prunus persica attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    J Med Food; 2008 Jun; 11(2):302-6. PubMed ID: 18598173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
    Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
    Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice.
    Hung YC; Huang GS; Lin LW; Hong MY; Se PS
    Food Chem Toxicol; 2007 Jul; 45(7):1123-30. PubMed ID: 17303299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.
    Nakashima-Kamimura N; Mori T; Ohsawa I; Asoh S; Ohta S
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):753-61. PubMed ID: 19148645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.
    Ajith TA; Jose N; Janardhanan KK
    J Exp Clin Cancer Res; 2002 Jun; 21(2):213-7. PubMed ID: 12148580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.
    Townsend DM; Hanigan MH
    J Pharmacol Exp Ther; 2002 Jan; 300(1):142-8. PubMed ID: 11752109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice.
    Kimura T; Nojiri T; Hosoda H; Ishikane S; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Cancer Chemother Pharmacol; 2015 May; 75(5):1057-63. PubMed ID: 25814217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds.
    Jones MM; Basinger MA; Holscher MA
    Fundam Appl Toxicol; 1992 Feb; 18(2):181-8. PubMed ID: 1601218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 615.